Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Purified Cannabidiol, the main non-psychotropic component of Cannabis sativa, alone, counteracts neuronal apoptosis in experimental multiple sclerosis.
P2X7 Receptor as a Therapeutic Target.
Microglia, physiology and behavior: A brief commentary.
Conformational Changes and Association of Membrane-Interacting Peptides in Myelin Membrane Models: A Case of the C-Terminal Peptide of Proteolipid Protein and the Antimicrobial Peptide Melittin.
Selective CB2 receptor activation ameliorates EAE by reducing Th17 differentiation and immune cell accumulation in the CNS.
NK-DC crosstalk controls the autopathogenic Th17 response through an innate IFN-γ-IL-27 axis.
Use of health services in people with multiple sclerosis with and without depressive symptoms: a two-year prospective study.
Systematic literature review and validity evaluation of the Expanded Disability Status Scale (EDSS) and the Multiple Sclerosis Functional Composite (MSFC) in patients with multiple sclerosis.
Hypertrophic pachymeningitis accompanying neuromyelitis optica spectrum disorder: A case report.
Brain characterization using normalized quantitative magnetic resonance imaging.
Are Polyphenols Strong Dietary Agents Against Neurotoxicity and Neurodegeneration?
Antiphospholipid antibodies: paradigm in transition.
Increased levels of CSF CD59 in neuromyelitis optica and multiple sclerosis.
A pilot study to improve adherence among MS patients who discontinue treatment against medical advice.
Guanosine inhibits LPS-induced pro-inflammatory response and oxidative stress in hippocampal astrocytes through the heme oxygenase-1 pathway.
The interactive web-based program MSmonitor for self-management and multidisciplinary care in multiple sclerosis: utilization and valuation by patients.
Demonstration of equivalence of a generic glatiramer acetate (Glatopa™).
Identification of genetic determinants of the sexual dimorphism in CNS autoimmunity.
Concentration of neddylation-related molecules in paranodal myelin of the peripheral nervous system.
How Does Transcranial Magnetic Stimulation Influence Glial Cells in the Central Nervous System?
Is there A Genetic Correlation between Multiple Sclerosis and Cerebral Aneurysms?
Nerve ultrasound protocol in differentiating chronic immune-mediated neuropathies.
Increased incidence of multiple sclerosis in systemic sclerosis: A nationwide cohort study.
Longitudinal Relationships between Caloric Expenditure and Gray Matter in the Cardiovascular Health Study.
Olfactory Ensheathing Cell Transplantation after a Complete Spinal Cord Transection Mediates Neuroprotective and Immunomodulatory Mechanisms to Facilitate Regeneration.
Pages
« first
‹ previous
…
669
670
671
672
673
674
675
676
677
…
next ›
last »